{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:50:08Z","timestamp":1791078608830,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","cell.com","clinicalkey.es","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.tips.2013.12.001","type":"journal-article","created":{"date-parts":[[2014,1,3]],"date-time":"2014-01-03T10:45:33Z","timestamp":1388745933000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Drugging unconventional targets: insights from Huntington's disease"],"prefix":"10.1016","volume":"35","author":[{"given":"Shenliang","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Palacino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Difiglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2013.12.001_bib0005","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0140-6736(85)91054-2","article-title":"Senile plaque amyloid, paired helical filaments, and cerebrovascular amyloid in Alzheimer's disease are all deposits of the same protein","volume":"1","author":"Kidd","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2013.12.001_bib0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.tips.2013.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1126\/science.1154584","article-title":"TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis","volume":"319","author":"Sreedharan","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.tips.2013.12.001_bib0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","article-title":"Huntington's disease","volume":"369","author":"Walker","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2013.12.001_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neuron.2012.05.024","article-title":"Network organization of the huntingtin proteomic interactome in mammalian brain","volume":"75","author":"Shirasaki","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.12.001_bib0035","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1371\/journal.pgen.0030082","article-title":"Huntingtin interacting proteins are genetic modifiers of neurodegeneration","volume":"3","author":"Kaltenbach","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0040","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.tips.2013.12.001_bib0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington's disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.tips.2013.12.001_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399403006549","article-title":"Huntington's disease: molecular basis of neurodegeneration","volume":"5","author":"Rubinsztein","year":"2003","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.tips.2013.12.001_bib0055","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nature02998","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","author":"Arrasate","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.tips.2013.12.001_bib0060","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nchembio.1308","article-title":"Proteostasis of polyglutamine varies among neurons and predicts neurodegeneration","volume":"9","author":"Tsvetkov","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0065","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)80623-6","article-title":"Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease","volume":"101","author":"Yamamoto","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0075","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.tips.2013.12.001_bib0080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2013.12.001_bib0085","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/brain\/awr333","article-title":"Six-month partial suppression of Huntingtin is well tolerated in the adult rhesus striatum","volume":"135","author":"Grondin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.tips.2013.12.001_bib0090","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1096\/fj.12-219220","article-title":"A novel human embryonic stem cell-derived Huntington's disease neuronal model exhibits mutant huntingtin (mHTT) aggregates and soluble mHTT-dependent neurodegeneration","volume":"27","author":"Lu","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.tips.2013.12.001_bib0095","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.12.001_bib0100","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2013.12.001_bib0105","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.12.001_bib0110","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts","volume":"19","author":"van Bilsen","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tips.2013.12.001_bib0115","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1471-4159.2008.05734.x","article-title":"Allele-specific silencing of mutant Huntington's disease gene","volume":"108","author":"Zhang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tips.2013.12.001_bib0125","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","author":"Hu","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0130","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1021\/bi101208k","article-title":"Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat","volume":"49","author":"Gagnon","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.tips.2013.12.001_bib0135","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2013.12.001_bib0140","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.12.001_bib0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cell.2012.08.002","article-title":"Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0150","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tips.2013.12.001_bib0155","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease","volume":"19","author":"McBride","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tips.2013.12.001_bib0160","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrm1742","article-title":"What is the role of protein aggregation in neurodegeneration?","volume":"6","author":"Ross","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0165","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1523\/JNEUROSCI.19-07-02522.1999","article-title":"Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology","volume":"19","author":"Gutekunst","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.12.001_bib0170","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1098\/rstb.1999.0451","article-title":"Are there multiple pathways in the pathogenesis of Huntington's disease?","volume":"354","author":"Aronin","year":"1999","journal-title":"Phillos. Trans. R. Soc. Lond. B: Biol. Sci."},{"key":"10.1016\/j.tips.2013.12.001_bib0175","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/ncomms3753","article-title":"Soluble forms of polyQ-expanded huntingtin rather than large aggregates cause endoplasmic reticulum stress","volume":"4","author":"Leitman","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tips.2013.12.001_bib0180","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1523\/JNEUROSCI.5865-09.2010","article-title":"Aberrant Rab11-dependent trafficking of the neuronal glutamate transporter EAAC1 causes oxidative stress and cell death in Huntington's disease","volume":"30","author":"Li","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tips.2013.12.001_bib0185","doi-asserted-by":"crossref","first-page":"13487","DOI":"10.1074\/jbc.M111.286609","article-title":"Native mutant huntingtin in human brain: evidence for prevalence of full-length monomer","volume":"287","author":"Sapp","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0190","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nchembio.694","article-title":"Identifying polyglutamine protein species in situ that best predict neurodegeneration","volume":"7","author":"Miller","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.cellbio.15.1.1","article-title":"Vacuolar import of proteins and organelles from the cytoplasm","volume":"15","author":"Klionsky","year":"1999","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ceb.2007.02.002","article-title":"Role of ubiquitin- and Ubl-binding proteins in cell signaling","volume":"19","author":"Kirkin","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0205","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2007.12.018","article-title":"Autophagy in the pathogenesis of disease","volume":"132","author":"Levine","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0210","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cell.2007.10.035","article-title":"Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice","volume":"131","author":"Komatsu","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0215","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1083\/jcb.200507002","article-title":"p62\/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death","volume":"171","author":"Bjorkoy","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0220","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.molcel.2010.04.007","article-title":"The selective macroautophagic degradation of aggregated proteins requires the PI3P-binding protein Alfy","volume":"38","author":"Filimonenko","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0225","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1126\/science.1204592","article-title":"TFEB links autophagy to lysosomal biogenesis","volume":"332","author":"Settembre","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.tips.2013.12.001_bib0230","doi-asserted-by":"crossref","first-page":"142ra197","DOI":"10.1126\/scitranslmed.3003799","article-title":"PGC-1\u03b1 rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function","volume":"4","author":"Tsunemi","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2013.12.001_bib0235","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1074\/jbc.M412042200","article-title":"Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes","volume":"280","author":"Jana","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0240","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nbt.1608","article-title":"Harnessing chaperone-mediated autophagy for the selective degradation of mutant huntingtin protein","volume":"28","author":"Bauer","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tips.2013.12.001_bib0245","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0250","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/cdd.2008.110","article-title":"Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies","volume":"16","author":"Sarkar","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.tips.2013.12.001_bib0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/hmg\/ddg109","article-title":"Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy","volume":"12","author":"Ravikumar","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0260","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200801099","article-title":"Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents","volume":"183","author":"Degtyarev","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0265","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1158\/0008-5472.CAN-08-4344","article-title":"Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells","volume":"69","author":"Bommareddy","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.tips.2013.12.001_bib0270","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-2008-15314","article-title":"Antioxidants in central nervous system diseases: preclinical promise and translational challenges","volume":"15","author":"Kamat","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.tips.2013.12.001_bib0275","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1093\/hmg\/ddq253","article-title":"Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease","volume":"19","author":"Underwood","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0280","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200504035","article-title":"Lithium induces autophagy by inhibiting inositol monophosphatase","volume":"170","author":"Sarkar","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0285","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/hmg\/ddm294","article-title":"A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin","volume":"17","author":"Sarkar","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0290","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","article-title":"Novel targets for Huntington's disease in an mTOR-independent autophagy pathway","volume":"4","author":"Williams","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0295","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/hmg\/ddq093","article-title":"Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease","volume":"19","author":"Rose","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0300","doi-asserted-by":"crossref","first-page":"26107","DOI":"10.1016\/S0021-9258(19)74287-2","article-title":"Dependence of hepatocytic autophagy on intracellularly sequestered calcium","volume":"268","author":"Gordon","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0305","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.1074\/jbc.M609532200","article-title":"Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and \u03b1-synuclein","volume":"282","author":"Sarkar","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0310","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1073\/pnas.0709695104","article-title":"Small molecule regulators of autophagy identified by an image-based high-throughput screen","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.12.001_bib0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pneurobio.2011.08.013","article-title":"Autophagy and polyglutamine diseases","volume":"97","author":"Jimenez-Sanchez","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tips.2013.12.001_bib0320","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/nrm2529","article-title":"Autophagic cell death: the story of a misnomer","volume":"9","author":"Kroemer","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0325","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin\u2013proteasome system by protein aggregation","volume":"292","author":"Bence","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.tips.2013.12.001_bib0330","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1097-2765(04)00151-0","article-title":"Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins","volume":"14","author":"Venkatraman","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0335","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4161\/auto.5.5.8704","article-title":"Enhanced degradation of mutant huntingtin by rho kinase inhibition is mediated through activation of proteasome and macroautophagy","volume":"5","author":"Bauer","year":"2009","journal-title":"Autophagy"},{"key":"10.1016\/j.tips.2013.12.001_bib0340","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1083\/jcb.200909067","article-title":"IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome","volume":"187","author":"Thompson","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0345","doi-asserted-by":"crossref","first-page":"27068","DOI":"10.1074\/jbc.M113.486076","article-title":"Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes","volume":"288","author":"Juenemann","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0350","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nn.3367","article-title":"Identification of NUB1 as a suppressor of mutant Huntington toxicity via enhanced protein clearance","volume":"16","author":"Lu","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2013.12.001_bib0355","doi-asserted-by":"crossref","first-page":"46655","DOI":"10.1074\/jbc.M108636200","article-title":"Targeting of NEDD8 and its conjugates for proteasomal degradation by NUB1","volume":"276","author":"Kamitani","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0360","doi-asserted-by":"crossref","first-page":"20603","DOI":"10.1074\/jbc.M100920200","article-title":"NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression","volume":"276","author":"Kito","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0365","doi-asserted-by":"crossref","first-page":"32905","DOI":"10.1074\/jbc.M212057200","article-title":"Regulation of the NEDD8 conjugation system by a splicing variant, NUB1L","volume":"278","author":"Tanaka","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0370","doi-asserted-by":"crossref","first-page":"16503","DOI":"10.1074\/jbc.M310114200","article-title":"NEDD8 ultimate buster-1L interacts with the ubiquitin-like protein FAT10 and accelerates its degradation","volume":"279","author":"Hipp","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0375","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nn.3380","article-title":"NUB1 snubs huntingtin toxicity","volume":"16","author":"Aron","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2013.12.001_bib0380","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1038\/sj.emboj.7600186","article-title":"Cullin-based ubiquitin ligases: Cul3\u2013BTB complexes join the family","volume":"23","author":"Pintard","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.tips.2013.12.001_bib0385","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1083\/jcb.200906117","article-title":"The Cul3\u2013KLHL21 E3 ubiquitin ligase targets aurora B to midzone microtubules in anaphase and is required for cytokinesis","volume":"187","author":"Maerki","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0390","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.devcel.2007.03.019","article-title":"A Cul3-based E3 ligase removes Aurora B from mitotic chromosomes, regulating mitotic progression and completion of cytokinesis in human cells","volume":"12","author":"Sumara","year":"2007","journal-title":"Dev. Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0395","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1212\/WNL.43.4.662","article-title":"Interferon \u03b2-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS\/MRI Study Group and the IFNB Multiple Sclerosis Study Group","volume":"43","author":"Paty","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.tips.2013.12.001_bib0400","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/brain\/awt061","article-title":"Interferon \u03b2 induces clearance of mutant ataxin 7 and improves locomotion in SCA7 knock-in mice","volume":"136","author":"Chort","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.tips.2013.12.001_bib0405","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/nn.2528","article-title":"Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease","volume":"13","author":"Martinez-Vicente","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tips.2013.12.001_bib0410","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.201110093","article-title":"Indirect inhibition of 26S proteasome activity in a cellular model of Huntington's disease","volume":"196","author":"Hipp","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tips.2013.12.001_bib0415","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.neuron.2009.11.020","article-title":"Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice","volume":"64","author":"Gu","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.12.001_bib0420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cell.2009.03.018","article-title":"Acetylation targets mutant huntingtin to autophagosomes for degradation","volume":"137","author":"Jeong","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0425","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1515\/REVNEURO.2010.21.4.273","article-title":"Antibody therapy in neurodegenerative disease","volume":"21","author":"Southwell","year":"2010","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.tips.2013.12.001_bib0430","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1074\/jbc.M111.294801","article-title":"A screen for enhancers of clearance identifies huntingtin as a heat shock protein 90 (Hsp90) client protein","volume":"287","author":"Baldo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tips.2013.12.001_bib0435","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1534\/genetics.109.112516","article-title":"A genome-wide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila","volume":"184","author":"Zhang","year":"2010","journal-title":"Genetics"},{"key":"10.1016\/j.tips.2013.12.001_bib0440","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuron.2010.06.021","article-title":"Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease","volume":"67","author":"Miller","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.12.001_bib0445","doi-asserted-by":"crossref","first-page":"e7275","DOI":"10.1371\/journal.pone.0007275","article-title":"RNAi screening in Drosophila cells identifies new modifiers of mutant huntingtin aggregation","volume":"4","author":"Doumanis","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tips.2013.12.001_bib0450","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","article-title":"Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes","volume":"11","author":"The","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tips.2013.12.001_bib0455","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuron.2010.12.035","article-title":"Huntington's disease: can mice lead the way to treatment?","volume":"69","author":"Crook","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.tips.2013.12.001_bib0460","series-title":"Neurobiology of Huntington's Disease: Applications to Drug Discovery","first-page":"165","article-title":"Mouse models for validating preclinical candidates for Huntington's disease","author":"William Yang","year":"2011"},{"key":"10.1016\/j.tips.2013.12.001_bib0465","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nature06975","article-title":"Towards a transgenic model of Huntington's disease in a non-human primate","volume":"453","author":"Yang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.tips.2013.12.001_bib0470","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1093\/hmg\/ddq313","article-title":"Expression of Huntington's disease protein results in apoptotic neurons in the brains of cloned transgenic pigs","volume":"19","author":"Yang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0475","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s12035-012-8316-3","article-title":"Mouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II","volume":"46","author":"Switonski","year":"2012","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tips.2013.12.001_bib0480","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01884-8","article-title":"Mouse models of Huntington's disease","volume":"23","author":"Menalled","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.tips.2013.12.001_bib0485","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10776","article-title":"Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats","volume":"465","author":"Menalled","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.tips.2013.12.001_bib0490","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/hmg\/ddm315","article-title":"Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases","volume":"17","author":"Branco","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0495","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0076-6879(06)12016-9","article-title":"Modeling polyglutamine pathogenesis in C. elegans","volume":"412","author":"Brignull","year":"2006","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.tips.2013.12.001_bib0500","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nature12204","article-title":"RAS\u2013MAPK\u2013MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1","volume":"498","author":"Park","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.tips.2013.12.001_bib0505","doi-asserted-by":"crossref","first-page":"e1003042","DOI":"10.1371\/journal.pgen.1003042","article-title":"A genome-scale RNA-interference screen identifies RRAS signaling as a pathologic feature of Huntington's disease","volume":"8","author":"Miller","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0510","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3233\/JHD-120033","article-title":"Pizotifen activates ERK and provides neuroprotection in vitro and in vivo in models of Huntington's disease","volume":"1","author":"Sarantos","year":"2012","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.tips.2013.12.001_bib0515","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/ng.2732","article-title":"Glutathione peroxidase activity is neuroprotective in models of Huntington's disease","volume":"45","author":"Mason","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0520","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ab.2009.08.001","article-title":"Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease","volume":"395","author":"Weiss","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tips.2013.12.001_bib0525","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","article-title":"A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo","volume":"102","author":"Zhang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.tips.2013.12.001_bib0530","doi-asserted-by":"crossref","first-page":"e1002481","DOI":"10.1371\/journal.pgen.1002481","article-title":"A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity","volume":"8","author":"Banez-Coronel","year":"2012","journal-title":"PLoS Genet."},{"key":"10.1016\/j.tips.2013.12.001_bib0535","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","article-title":"Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells","volume":"11","author":"An","year":"2012","journal-title":"Cell Stem Cell"}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614713002289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614713002289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T09:11:53Z","timestamp":1647853913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614713002289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":107,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0165614713002289"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2013.12.001","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drugging unconventional targets: insights from Huntington's disease","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2013.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}